Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_assertion type Assertion NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_head.
- NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_assertion description "[The patient was treated with an HD-CAV chemotherapy regimen (cyclophosphamide, doxorubicin, vincristine, ifosfamide, etoposide) and was free of tumor until 18 months later, at which time he developed multiple metastases in the lungs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_provenance.
- NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_assertion evidence source_evidence_literature NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_provenance.
- NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_assertion SIO_000772 10555010 NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_provenance.
- NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_assertion wasDerivedFrom befree-2016 NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_provenance.
- NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_assertion wasGeneratedBy ECO_0000203 NP267289.RAmxoXBphF2I-m-t7HvTIuw6qSkSgNmkUdcuedmVBZ59k130_provenance.